How should truncal (axial) weakness be evaluated and managed in an adult when a myopathy is suspected?

Truncal Weakness in Myopathies: Evaluation and Management

When truncal (axial) weakness is present in a suspected myopathy, immediately recognize this as a significant diagnostic clue that narrows your differential and requires targeted paraspinal muscle evaluation with MRI and biopsy, as axial involvement occurs in the majority of myopathies examined and is often severe and early even in diseases traditionally named for limb involvement 1.

Key Clinical Recognition

Truncal weakness manifests as:

• Difficulty maintaining upright trunk and head position (bent spine, dropped head)
• Symptoms improve when supine - a critical distinguishing feature
• Often underrecognized because progressive cervical kyphosis is mistakenly attributed to normal aging 2

This pattern is NOT rare - axial musculature is involved in the majority of myopathies when specifically examined, including facioscapulohumeral and limb-girdle muscular dystrophies where axial involvement can be severe and early despite the disease names suggesting otherwise 1.

Diagnostic Approach

1. Initial Laboratory Assessment

• Serum CK levels: Normal to slightly elevated in pure axial myopathy 2; markedly elevated suggests inflammatory or necrotizing myopathy 3
• Myositis-specific autoantibodies (anti-Jo-1, anti-Mi2, anti-SRP) to identify inflammatory myopathies 3
• Serum protein electrophoresis: Essential to exclude amyloidosis, which can present as isolated axial myopathy 4
• Thyroid function, electrolytes to exclude endocrine/metabolic causes 3

2. Imaging - MRI is Critical

MRI of paraspinal and neck extensor muscles using T1-weighted, T2-weighted, and STIR sequences 3:

• T2-weighted/STIR: Identifies active muscle edema and inflammation
• T1-weighted: Shows chronic muscle damage, atrophy, and fat replacement
• Dual purpose: Confirms axial involvement AND guides optimal biopsy site selection 3, 1

3. Electromyography

Perform EMG for two specific reasons 3:

1. Confirm myopathic process: Polyphasic motor unit action potentials of short duration and low amplitude with increased insertional activity, fibrillation potentials, and sharp waves
2. Target weak muscle for biopsy - examine the contralateral side of the EMG-abnormal muscle 3

4. Muscle Biopsy - Gold Standard

Biopsy the paraspinal or neck extensor muscles when axial weakness predominates 3, 2:

• Choose a weak muscle identified by EMG abnormalities
• Biopsy the opposite side from EMG testing
• Essential for differentiating:
  • Inflammatory myopathies: CD8+ T-cell invasion (polymyositis), perifascicular atrophy (dermatomyositis), minimal inflammation with necrosis (immune-mediated necrotizing myopathy) 3
  • Muscular dystrophies: Dystrophin reduction/absence, fiber degeneration/regeneration, fat/connective tissue replacement 3
  • Mitochondrial myopathies: Ragged red fibers on Gomori trichrome, cytochrome c oxidase deficiency 3
  • Amyloidosis: Amyloid deposition around muscle fibers and blood vessels 4

Critical Differential Diagnosis for Axial Myopathy

Inflammatory Myopathies

• Polymyositis/Dermatomyositis: Symmetric proximal weakness (including trunk), elevated CK, responds to immunosuppression 3
• Inclusion body myositis: Most common myopathy after age 50; consider if slowly progressive 5

Muscular Dystrophies

• Limb-girdle muscular dystrophies: Despite the name, often have significant early axial involvement 1
• Facioscapulohumeral dystrophy: Asymmetric facial and scapulohumeral weakness, but axial muscles frequently affected 1

Metabolic/Systemic

• Primary amyloidosis: Can present as isolated axial myopathy with monoclonal gammopathy 4
• Endocrine myopathies: Thyroid disorders, hyperparathyroidism 3

Pure Axial Myopathy

• Rare entity with selective spinal muscle involvement, age of onset 35-56 years, slowly progressive 2

Management Algorithm

For Inflammatory Myopathies (if confirmed):

Initiate high-dose corticosteroids (prednisone 1 mg/kg/day) PLUS a steroid-sparing agent from day one 3:

• First-line steroid-sparing agents: Methotrexate, azathioprine, or mycophenolate mofetil
• Taper corticosteroids after 2-4 weeks based on response
• For severe/refractory disease: Add IV methylprednisolone, IVIG, rituximab, cyclophosphamide, or cyclosporine 3

For Non-Inflammatory Myopathies:

• Muscular dystrophies: Genetic counseling, supportive care, physical therapy
• Amyloidosis: Chemotherapy for underlying plasma cell disorder 4
• Endocrine: Treat underlying hormonal abnormality

Common Pitfalls to Avoid

1. Dismissing bent spine/dropped head as "normal aging" - Always investigate if progressive or associated with functional impairment 2
2. Assuming myopathy only affects limbs - Axial involvement is the rule, not the exception 1
3. Biopsying only limb muscles when axial weakness predominates - You'll miss the diagnosis 2
4. Delaying steroid-sparing agents in inflammatory myopathy - Start concurrently with corticosteroids to minimize steroid toxicity 3
5. Missing amyloidosis - Always check serum protein electrophoresis in unexplained axial myopathy 4

Monitoring and Prognosis

• Serial MRI to monitor treatment response in inflammatory myopathies 3
• Functional assessments: Ability to maintain upright posture, activities of daily living
• Pure axial myopathy is slowly progressive; inflammatory myopathies respond to immunosuppression if treated early 3, 2